Tianjin Huanhu Hospital
Clinical trials sponsored by Tianjin Huanhu Hospital, explained in plain language.
-
Protein shot aims to boost stroke recovery after clot removal
Disease control Not yet recruitingThis study tests if adding a protein called albumin directly into the brain's arteries right after a successful clot-removal procedure helps people recover better from a major stroke. It will compare the standard clot-removal procedure alone against the procedure plus an albumin …
Phase: PHASE2 • Sponsor: Tianjin Huanhu Hospital • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New stroke treatment aims to protect the brain after clot removal
Disease control Not yet recruitingThis study is testing if adding a protein called albumin directly into the brain's arteries right after a successful clot removal procedure can help protect brain tissue and reduce long-term damage from a major stroke. It will involve 60 patients who have had a stroke caused by a…
Phase: PHASE2 • Sponsor: Tianjin Huanhu Hospital • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC
-
Universal cell therapy trial aims to tame rogue immune system in devastating neurological diseases
Disease control Not yet recruitingThis early-phase study is testing a new 'off-the-shelf' cell therapy for people with severe neurological autoimmune diseases that have not responded to other treatments. Up to 15 participants with conditions like multiple sclerosis or myasthenia gravis will receive a single infus…
Phase: EARLY_PHASE1 • Sponsor: Tianjin Huanhu Hospital • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC